Published in Pacing Clin Electrophysiol on December 01, 2000
Special problems of pacing in children. Indian Pacing Electrophysiol J (2003) 0.98
Inferior vena caval loop of an endocardial pacing lead did not solve the growth problem in a child. Pacing Clin Electrophysiol (2001) 0.81
Pacing device therapy in infants and children: a review. J Artif Organs (2012) 0.81
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17
A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med (2000) 2.02
Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem (2001) 1.78
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel. Circ Res (2001) 1.72
Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol (2001) 1.71
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J (2000) 1.59
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet (1999) 1.43
Brugada syndrome and sudden cardiac death in children. Lancet (2000) 1.40
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol (2000) 1.24
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res (1987) 1.20
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol (1993) 1.18
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis (2013) 1.01
Torsade de pointes. Mechanisms and management. Drugs (1994) 1.01
Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol (2000) 1.00
Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy. Am J Cardiol (1983) 0.98
Developments, complications and limitations of catheter-mediated electrical ablation of posterior accessory atrioventricular pathways. Am J Cardiol (1988) 0.95
Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation (1988) 0.93
Some factors affecting bubble formation with catheter-mediated defibrillator pulses. Circulation (1986) 0.93
Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. Am Heart J (1995) 0.92
Anatomic and electrophysiologic substrate of the permanent form of junctional reciprocating tachycardia. J Am Coll Cardiol (1984) 0.92
Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium. A possible mechanism for reperfusion arrhythmias. Circulation (1990) 0.91
Catheter-mediated electrical ablation: the relation between current and pulse width on voltage breakdown and shock-wave generation. Circ Res (1988) 0.88
Antegrade slow bypass conduction after closed-chest ablation of the His bundle in permanent junctional reciprocating tachycardia. Circulation (1983) 0.87
Exploring the hidden danger of noncardiac drugs. J Cardiovasc Electrophysiol (1998) 0.85
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. J Am Coll Cardiol (1997) 0.84
Alterations in ultrasonic backscatter during exercise-induced myocardial ischemia in humans. Circulation (1995) 0.84
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol (1995) 0.83
Congestive heart failure induced by recipient atrial tachycardia conducted to the donor atrium after orthotopic heart transplantation: complete regression after successful radiofrequency ablation. J Cardiovasc Electrophysiol (1999) 0.82
Closed chest modification of atrioventricular conduction system in man for treatment of refractory supraventricular tachycardia. Br Heart J (1983) 0.82
Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2013) 0.82
Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: a 12-year single-center experience. Surgery (1996) 0.81
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. Hong Kong Med J (2004) 0.80
Mechanism of tachycardia using a nodofascicular Mahaim fiber. Am J Cardiol (1984) 0.80
Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response. Am Heart J (1984) 0.80
Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation (1999) 0.80
Effects of varying electrode configuration with catheter-mediated defibrillator pulses at the coronary sinus orifice in dogs. Circulation (1986) 0.79
Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia: principal component analysis of the ST-T waves. Circulation (1997) 0.79
Catheter-mediated electrical ablation of the posterior septum via the coronary sinus: electrophysiologic and histologic observations in dogs. Circulation (1985) 0.78
Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace (1999) 0.78
Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate. Eur Heart J (1995) 0.78
Brugada syndrome and sudden death. Eur Heart J (2000) 0.78
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. Ital Heart J Suppl (2001) 0.77
Should ablation of atrial flutter be discouraged in patients with documented atrial fibrillation? Cardiologia (1999) 0.77
Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine. J Clin Endocrinol Metab (1998) 0.77
Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol (1999) 0.77
Long-term follow-up after atrioventricular nodal ablation and pacing: low incidence of sudden cardiac death. Pacing Clin Electrophysiol (2000) 0.76
Cardiovascular safety of second-generation antihistamines. Am J Rhinol (1999) 0.76
From catheters to vectors: the dawn of molecular electrophysiology. Nat Med (2000) 0.76
Efficacy of diltiazem in two experimental feline models of sudden cardiac death. J Am Coll Cardiol (1986) 0.76
Foretelling the future in Brugada syndrome: do we have the crystal ball? J Cardiovasc Electrophysiol (2001) 0.76
Is long QT syndrome entering the era of molecular diagnosis? Heart (1997) 0.75
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. Heart (1999) 0.75
Arterial baroreflexes and ventricular tachycardia. Circulation (1997) 0.75
1A.08: GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS. J Hypertens (2015) 0.75
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias. Eur Heart J (1988) 0.75
Use of extended donors in high-risk renal transplant recipients: a 2-year single-center experience. Transplant Proc (1996) 0.75
[An experimental model of catheter-mediated electrical ablation applied at the proximal coronary sinus: histological, electrophysiological and physical effects]. Cardiologia (1988) 0.75
Significance of QT dispersion in the long QT syndrome. Prog Cardiovasc Dis (2000) 0.75
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. Am Heart J (1989) 0.75
Feasibility and safety of two French electrode catheters in the performance of electrophysiological studies. Pacing Clin Electrophysiol (1998) 0.75
[Work experience of the health assistants in the Seveso area]. Prof Inferm (1978) 0.75
Double tachycardia following surgery for recurrent ventricular arrhythmias. G Ital Cardiol (1986) 0.75
Deceptive surgical results in three siblings with familial Wolff-Parkinson-White syndrome. Eur Heart J (1990) 0.75
Catheter-mediated electrical ablation: the relation between current and pulse width on voltage breakdown and shock-wave generation. Pacing Clin Electrophysiol (1986) 0.75
Egg quality and productive performance of laying hens fed different levels of skimmed milk powder added to a diet containing Lactobacillus acidophilus. Poult Sci (2014) 0.75
Italian survey on allogeneic BMT for chronic myeloid leukaemia. Bone Marrow Transplant (1989) 0.75
The Barnes-Jewish Hospital/Washington University Renal Transplant Program: comparison of two eras 1991-1994 and 1995-2000. Clin Transpl (2001) 0.75
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium. Cardiovasc Drugs Ther (1991) 0.75
Electrophysiologic and histopathologic correlations in a case of permanent form of reciprocating tachycardia. Eur Heart J (1985) 0.75
Influence of residual ischaemia on heart rate variability after myocardial infarction. Eur Heart J (1997) 0.75
The automatic implantable cardioverter/defibrillator: transesophageal atrial pacing discloses the potential for erroneous discharges. Pacing Clin Electrophysiol (1988) 0.75
Catheter ablation of a concealed accessory pathway. Am J Cardiol (1984) 0.75
Radiofrequency modification of the atrioventricular node in patients with chronic atrial fibrillation: comparison between anterior and posterior approaches. J Cardiovasc Electrophysiol (1998) 0.75
Effect of damped sine-wave shocks on catheter dielectric strength. Am J Cardiol (1985) 0.75
Microcirculation and hemorheology in NIDDM patients. Angiology (1990) 0.75
[The non-contact mapping]. Cardiologia (1999) 0.75
Noncontact system-guided simplified right atrial linear lesions using radiofrequency transcatheter ablation for treatment of refractory atrial fibrillation. Pacing Clin Electrophysiol (2000) 0.75
[Genetic basis of sudden cardiac death]. Recenti Prog Med (2000) 0.75
Isradipine in the treatment of peripheral occlusive vascular disease of the lower limbs: a pilot study. J Int Med Res (1992) 0.75
Paradoxical delay in accessory pathway conduction during long R-P' tachycardia after interpolated ventricular premature complexes. Am J Cardiol (1985) 0.75